Align Technology Inc (ALGN) is not an optimal buy at this moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in its latest quarter and positive analyst sentiment, the current technical indicators suggest a bearish trend. Additionally, the lack of significant positive catalysts, absence of recent congress trading data, and neutral hedge fund and insider trading activity make it prudent to wait for a better entry point.
The technical indicators show a bearish sentiment. The MACD histogram is negative and expanding, indicating downward momentum. RSI is at 25.813, which is close to oversold territory but not yet a clear buy signal. Moving averages are converging, and the stock is trading near its S1 support level of 176.876, with further downside risk to S2 at 172.466.

Strong Q4 financial performance with revenue up 5.26% YoY and net income up 30.78% YoY.
Analysts have raised price targets, with several maintaining Buy or Outperform ratings.
Positive long-term outlook due to growth in adult aligner shipments and advancements in 3D printing technology.
The stock has seen a significant price decline recently, with a -3.60% regular market change.
Gross margin dropped by -6.73% YoY in Q4, indicating potential cost pressures.
No recent news or event-driven catalysts to drive immediate upside.
Align Technology reported strong Q4 2025 financials, with revenue increasing by 5.26% YoY to $1.047 billion, net income rising by 30.78% YoY to $135.76 million, and EPS up 35.97% YoY to 1.89. However, gross margin dropped to 65.32%, down -6.73% YoY, which could indicate rising costs or pricing pressures.
Analyst sentiment is positive, with multiple firms raising price targets to $200-$220 and maintaining Buy or Outperform ratings. Analysts highlight strong Q4 results, international growth, and improving sentiment in the dental space as key drivers for the stock's long-term potential.